Augmented Reality For MRI-Guided Interventions

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age3-21
SponsorChildren's National Research Institute

About this trial

The purpose of this study is to determine feasibility and safety of using an augmented reality system in patients undergoing MRI-Guided needle procedures.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Provision of signed and dated informed consent form

Stated willingness to comply with all study procedures and availability for the duration of the study

Male or female, ages 3 to 21

Patient referred to Interventional Radiology for image-guided needle injection, aspiration, or biopsy.

Disqualifiers

Patients who are unable to give informed consent themselves or through their parents.

Patients under 3 years of age

Patients over 300 pounds.

Patients who are claustrophobic and unable to tolerate MRI-guided procedure.

Trial design

Design model

Single group

Treatments tested in this trial

  • Augmented Reality System

    Device

    Subjects will undergo image guided needle aspiration, injection, or biopsy facilitated by the Augmented Reality system. The Augmented Reality guidance system will be operated by the interventional radiologist in the MRI suite.

Treatment groups

25 Participants
are divided into 1 treatment group
Group A: Patients Undergoing Augmented Reality Image-Guided Needle ProceduresExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Feasibility is measured by successful completion of greater than 80% of cases using the augmented reality needle guidance system.

Time frame
1 day
2

Safety of using the augmented reality needle guidance system will be evaluated through assessment of procedure related adverse events that occur within 7 days of the procedure.

Time frame
7 days

Secondary outcomes

1

Procedure time

Total procedure time.

Time frame
1 day
2

Number of MRI scans

Number of MRI scans needed to complete the procedure, and size and depth of target will be recorded.

Time frame
1 day
3

Clinical impressions of the system use and utility

The operator will complete a usability form that captures ease of use using the Likert scale.

Time frame
1 Day

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.